ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1559

Routine Clinical Pathology Measurements Are Predictive of the Risk of Organ Damage Accrual in SLE

Eric Morand1, Kevin Zhang 1, Sarah Boyd 1, Francois Petitjean 1, Alberta Hoi 2, Rachel Koelmeyer 1 and Hieu Nim 1, 1Monash University, Melbourne, Victoria, Australia, 2School of Clinical Sciences, Monash University, Meloburne, Victoria, Australia

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: damage and laboratory tests, Disease Activity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Clinical Poster II: Comorbidities

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Prevention of permanent organ damage, a major predictor of morbidity and mortality, is a key goal in the treatment of SLE. Physician-measured disease activity scores have only weak predictive value for damage accrual risk, and are in part subjective. Routine pathology laboratory measurements provide objective, continuous biological data, but their association with damage accrual risk in SLE has not been studied.

Methods: Longitudinal data were collected prospectively in a single centre SLE patient cohort between 2007-2017. Variables recorded at each visit included disease activity (SLEDAI-2k), drug treatment and routine pathology measurements. Organ damage (SLICC-SDI) was measured annually. Longitudinal patient data were split into annual periods, and each visit was assigned as being in a “damage transition” or “non-damage transition” period based on whether SDI increased at the subsequent annual measure. Time-adjusted means (TAMs) of laboratory variables were calculated for each period, and multivariable logistic regression analysis of the association with damage accrual (adjusting for age, gender, race, previous organ damage and prednisolone dose) was performed, with Holm-Bonferroni correction.

Results: 893 annual periods, comprising 5082 visits from 245 patients (85.6% female, 50.2% Caucasian), were analysed. Five of 16 routine laboratory variables were significantly associated with risk of damage accrual: estimated glomerular filtration rate (eGFR) (p< 0.01), creatinine (p< 0.01), urine protein:creatinine ratio (p< 0.01), ESR (p< 0.001), and haemoglobin (p< 0.001). Moreover, the odds of damage increase were proportional to the deviation of each of these variables from its respective normal range (Figure). SLEDAI-2k was also significantly associated with damage accrual (p< 0.001), but the association of SLEDAI-2k with damage did not exhibit this proportionality.

Conclusion: Routine pathology measures are proportionally associated with organ damage risk in SLE. These measures have potential as biomarkers for identifying patients at risk of organ damage from SLE.

Ln -natural log- odds ratio for damage transition vs time-adjusted mean of laboratory variables. Red region -95%CI- lying above the y=0 line indicates the risk is statistically significant -p<0.05-. Regression lines -blue- indicate the risk of damage increase is approximately proportional with the distance from normal pathology measure range.


Disclosure: E. Morand, AstraZeneca, 2, 5, 8, Bristol Myers Squibb, 2, Eli Lilly, 5, Janssen, 2, 5, Merck Serono, 2, 5, UCB, 2; K. Zhang, None; S. Boyd, None; F. Petitjean, None; A. Hoi, Merck, 2; R. Koelmeyer, None; H. Nim, None.

To cite this abstract in AMA style:

Morand E, Zhang K, Boyd S, Petitjean F, Hoi A, Koelmeyer R, Nim H. Routine Clinical Pathology Measurements Are Predictive of the Risk of Organ Damage Accrual in SLE [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/routine-clinical-pathology-measurements-are-predictive-of-the-risk-of-organ-damage-accrual-in-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/routine-clinical-pathology-measurements-are-predictive-of-the-risk-of-organ-damage-accrual-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology